That's one way to take the pressure off.*
From Newsweek, June 26:
Danish drug manufacturer Novo Nordisk announced a $4.1 billion investment to expand its U.S. manufacturing capacity in Clayton, North Carolina.
In one of the largest investments in the firm's history, the planned expansion will add 1.4 million square feet of production space for aseptic manufacturing and finished production processes.
The new plant will double the combined square footage of the company's three existing North Carolina facilities, adding 1,000 new jobs to the almost 2,500 Novo Nordisk employees already working in the region, with 2,000 external contractors expected to be utilized at the height of the project.
Newsweek has reached out to Novo Nordisk for comment....
....MUCH MORE
* Novo Nordisk CEO Will Explain To American Senators Why Ozempic Costs 15x More In The U.S. Than, Say, In Germany
Related: "Sales Of Weight Loss Drugs Ozempic and Wegovy Now Account For Most Of Denmark's Economic Growth"
